(1R,4aR,5S,6S,6aS,9S,11S,11aS,11bS)-1,5,6,11-四羟基-4,4-二甲基-8-亚甲基十氢-1H-6,11b-(环氧甲撑)-6a,9-甲撑环庚烷并[a]萘-7(8H)-酮

Volociximab

Ipilimumab

8-((苄巯基)甲基)-1,3-二甲基-1H-嘌呤-2,6(3H,7H)-二酮

蒽并[1,2-c][1,2,5]噻二唑-6,11-二酮

1,3,5-三羟基-2,4-双(3-甲基丁-2-烯-1-基)-9H-氧杂蒽-9-酮

5-羟基-2-(4-甲氧基苯基)-7-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-氧基))-4H-苯并吡喃-4-酮

Catumaxomab

Neurotensin (9CI, ACI)

Immunoglobulin G1, anti-(human CD25 antigen) (human monoclonal RG6292 γ1-chain), disulfide with human monoclonal RG6292 κ-chain, dimer (ACI)

2-((3-(4-(2-(叔丁基)-6-(三氟甲基)嘧啶-4-基)哌嗪-1-基)丙基)硫基)嘧啶-4(3H)-酮

1-甲基吲哚啉-2,3-二酮

3,5,7-三羟基-8-甲氧基-2-(4-甲氧基苯基)-4H-苯并吡喃-4-酮

2-甲氧基-1,2-二苯基乙酮

(1aR,2S,5R,5aR,6S,8aS,9R,10aR)-5,5a,6-三羟基-4-(羟甲基)-1,1,7,9-四甲基-1a,2,5,5a,6,9,10,10a-八氢-1H-2,8a-甲撑环庚烷并[a]环丙烷并[e][10]轮烯-11-酮

Immunoglobulin G1 [235-alanine,236-alanine,434-lysine,435-phenylalanine], anti-(human complement component 2) (human monoclonal ARGX-117 γ1-chain), disulfide with human monoclonal ARGX-117 κ-chain, dimer (ACI)

Immunoglobulin G2 [de-446-lysine], anti-(human immunoglobulin-like domain-containing receptor 2) (human monoclonal BAY 1905254 γ2-chain), disulfide with human monoclonal BAY 1905254 κ-chain, dimer (ACI)

Immunoglobulin G1, anti-(human granulocyte-macrophage colony-stimulating factor) (human monoclonal TJ003234 γ1-chain), disulfide with human monoclonal TJ003234 κ-chain, dimer (ACI)

Immunoglobulin IgG1, anti-(human receptor tyrosine kinase Axl) (human-Mus musculus monoclonal BGB149 γ1-chain), disulfide with human-Mus musculus monoclonal BGB149 κ-chain, dimer (ACI)

Immunoglobulin G4, anti-(human B and T lymphocyte attenuator (BTLA)) (human-Mus musculus monoclonal JS004 γ4-chain), disulfide with human-Mus musculus monoclonal JS004 κ-chain, dimer (ACI)

Visilizumab